(828 days)
The 900PT561 heated breathing tube is for delivery of humidified respiratory gases. For use with AIRVO™ and AIRVO™ 2 Series humidifiers in hospitals and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.
The 900PT560 and 900PT560E heated breathing tube is for delivery of humidified respiratory gases. For use with myAIRVO™ and myAIRVO™ 2 Series humidifiers in homes and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.
Compatible patient interfaces: nasal cannula, tracheostomy direct connection, mask adapter.
The AirSpiral heated breathing tube is an accessory to the AIRVO 2 Series Humidifiers and comes in various packaging configurations with or without a humidification chamber, for hospital, long term care, or home use. The tube wall is made from air filled plastic spirally wound in a concentric manner to form the lumen. The trapped air in the plastic utilizes the thermal insulation properties of air. The heater wire is also wound into the wall of the tube to provide direct heating of the tube wall instead of being placed in the gas path. These features help reduce condensation inside the tube.
The AirSpiral heated breathing tube represents an alternative to the existing predicated heated breathing tube accessory in the predicate AIRVO 2 Series Humidifier K131895. It is provided in the same packaging configurations, can be used on AIRVO and AIRVO 2 Series humidifiers over the complete flow range, and uses similar patient interfaces, as the predicate breathing tube and patient interfaces. The patient interfaces consist of Nasal Cannula, Tracheostomy Direct Connection, and Mask Interface Adapter. Of the nasal cannula, spare part Wigglepads for Junior nasal cannula are available to replace those fitted on the cannula if needed. They provide adhesion to hold the cannula in place on the patient. Humidification chambers consist of an autofeed chamber with feedset, and a manual fill chamber, to contain water for humidification.
The document describes the acceptance criteria and the studies conducted to demonstrate the substantial equivalence of the AirSpiral Heated Breathing Tube to its predicate device.
Here's an analysis of the requested information:
1. Table of Acceptance Criteria and Reported Device Performance
| Test Category | Acceptance Criteria | Reported Device Performance |
|---|---|---|
| I. Non-Clinical Performance | ||
| Condensation | (Implied: Show an improvement in condensate accumulation over the predicate line of tubes.) | Passed (showed an improvement in condensate accumulation over the predicate line of tubes) |
| Pressure Loss with Bending | (Not explicitly stated, but implied as meeting acceptable levels for device function.) | Passed |
| Leak Testing | (Not explicitly stated, but implied as no leaks with or without an interface.) | Passed |
| Connection Forces | (Not explicitly stated, but implied as appropriate connection forces for each connector.) | Passed |
| Tensile Strength | (Not explicitly stated, but implied as sufficient tensile strength for the tube.) | Passed |
| Useful Life | Tubes will last at least 2 weeks in hospital/long-term care, and 60 days in home/long-term care environments, and pass leak test, electrical test, and pull test. | Passed (Tubes met the useful life requirements for all environments, passing leak, electrical, and pull tests.) |
| Biocompatibility | Evaluation in accordance with FDA guidance document "Use of International Standard ISO 10993-1," for Cytotoxicity, Sensitization, Muscle Implantation, Genotoxicity, and Extractables/Leachables. Toxicological risk assessment based on chemical characterization following ISO 10993-17 with calculated margin of safety. | Passed (Biocompatibility evaluation conducted and passed for Cytotoxicity, Sensitization, Muscle Implantation, Genotoxicity, and Extractables/Leachables. Toxicological risk assessment with calculated margin of safety for each chemical characterized was performed and passed.) |
| Compatibility with Oxygen | Device to be compatible with oxygen under normal and single-fault conditions. | Passed |
| Environmental (ISTA 2A) | Device to function normally after storage, transportation, and drop testing. | Passed |
| II. System Performance (ISO 8185:2007, in conjunction with AIRVO 2 Series Humidifiers) | ||
| Max Accessible Surface Temp | Surface temperature < 44 °C (25 cm from patient connection port) | Met (Surface temperature < 44 °C) |
| Max Delivered Gas Temp (Normal Use) | Delivered temperature < 43 °C | Met (Delivered temperature < 43 °C) |
| Heating Interruption (Single Fault) | Heating stopped when delivered gas temperature > 43 °C | Met (Heating was interrupted when delivered gas temperature exceeded 43 °C) |
| Max Thermal Overshoot Enthalpy | Overshoot specific enthalpy < 194 kJ.kg-1 | Met (Overshoot specific enthalpy < 194 kJ.kg-1) |
| Minimum Humidity Output | > 33 mg.L-1 for invasive patient interfaces; > 10 mg.L-1 for non-invasive patient interfaces | Met (Humidity output > 33 mg.L-1 for invasive patient interfaces and > 10 mg.L-1 for non-invasive patient interfaces) |
2. Sample Size Used for the Test Set and Data Provenance
The document does not specify exact sample sizes for each non-clinical test (e.g., how many tubes were tested for condensation, useful life, etc.). It generally states that "The AirSpiral Heated Breathing Tubes passed the acceptance criteria for all tests."
- Test Set Sample Size: Not explicitly stated for most tests, but testing was performed on "The AirSpiral Heated Breathing Tubes" which implies a representative sample.
- Data Provenance: The studies were non-clinical performance and biocompatibility tests conducted by the manufacturer, Fisher & Paykel Healthcare, based in Auckland, New Zealand. The data is thus internal, prospective test data generated specifically for this submission.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This section is not applicable as the studies were non-clinical performance and biocompatibility tests, not studies requiring expert review of medical images or data from human subjects to establish ground truth. The "ground truth" here is objective physical and chemical measurements against defined engineering and regulatory standards.
4. Adjudication Method for the Test Set
This is not applicable for non-clinical performance and biocompatibility testing. Ground truth was established through validated measurement methods and adherence to scientific and regulatory standards (e.g., ISO 8185, ISO 10993).
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance
This is not applicable. The device is a heated breathing tube, not an AI-powered diagnostic or assistive tool for human readers. No MRMC studies were conducted or relevant.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done
This is not applicable. The device is a medical accessory (heated breathing tube), not an algorithm. Therefore, no standalone algorithm performance was assessed.
7. The Type of Ground Truth Used
The ground truth for the tests was based on:
- Pre-defined engineering specifications and performance targets (e.g., for pressure loss, tensile strength, condensation reduction).
- Compliance with recognized international standards (e.g., ISO 8185:2007 for system performance, IEC 60601-1 for electrical safety, ISO 10993 series for biocompatibility).
- Regulatory requirements laid out in FDA guidance documents.
8. The Sample Size for the Training Set
This is not applicable. The device is a physical medical component, not a machine learning or AI model. Therefore, no "training set" in the context of AI development was used.
9. How the Ground Truth for the Training Set Was Established
This is not applicable, as there was no training set used for an AI model.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
December 20, 2018
Fisher & Paykel Healthcare Brett Whiston Senior Regulatory Affairs Specialist 15 Maurice Paykel Place, East Tamaki Auckland, 2013 NZ
Re: K162553
Trade/Device Name: AirSpiral Heated Breathing Tube Regulation Number: 21 CFR 868.5450 Regulation Name: Respiratory gas humidifier Regulatory Class: Class II Product Code: BTT Dated: December 12, 2018 Received: December 14, 2018
Dear Brett Whiston:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
{1}------------------------------------------------
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice
(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
James J. Lee -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K162533
Device Name AirSpiral Heated Breathing Tube
Indications for Use (Describe)
The 900PT561 heated breathing tube is for delivery of humidified respiratory gases. For use with AIR VO™ and AIRVO™ 2 Series humidifiers in hospitals and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.
The 900PT560 and 900PT560E heated breathing tube is for delivery of humidified respiratory gases. For use with myAIRVO™ and myAIRVO™ 2 Series humidifiers in homes and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) Summarv
| Contact person/submitter | Brett Whiston |
|---|---|
| Date prepared | 20 December 2018 |
| Contact details | Address: 15 Maurice Paykel PlaceEast TamakiAuckland 2013, New ZealandTelephone: +64 9 574 0100Fax: +64 9 574 0158 |
| Trade name | AirSpiral Heated Breathing Tube |
| Common name | Humidifier |
| Classification name | Respiratory gas humidifierClass II (21 CFR §868.5450), product code BTT |
| Predicate device | 900PT501 and 900PT531 Heated Breathing Tubes inK131895, AIRVO 2 Series Humidifier, Fisher & PaykelHealthcare Ltd |
Device Description
AirSpiral Heated Breathing Tube
The AirSpiral heated breathing tube is an accessory to the AIRVO 2 Series Humidifiers and comes in various packaging configurations with or without a humidification chamber, for hospital, long term care, or home use. The tube wall is made from air filled plastic spirally wound in a concentric manner to form the lumen. The trapped air in the plastic utilizes the thermal insulation properties of air. The heater wire is also wound into the wall of the tube to provide direct heating of the tube wall instead of being placed in the gas path. These features help reduce condensation inside the tube.
The AirSpiral heated breathing tube represents an alternative to the existing predicated heated breathing tube accessory in the predicate AIRVO 2 Series Humidifier K131895. It is provided in the same packaging configurations, can be used on AIRVO and AIRVO 2 Series humidifiers over the complete flow range, and uses similar patient interfaces, as the predicate breathing tube and patient interfaces. The patient interfaces consist of Nasal Cannula, Tracheostomy Direct Connection, and Mask Interface Adapter. Of the nasal cannula, spare part Wigglepads for Junior nasal cannula are available to replace those fitted on the cannula if needed. They provide adhesion to hold the cannula in place on the patient. Humidification chambers consist of an autofeed chamber with feedset, and a manual fill chamber, to contain water for humidification.
The Air Spiral models are as follows; (Note: the AirSpiral breathing tube is the same in all configurations)
| Model | Configuration | Environment |
|---|---|---|
| 900PT561 | Air Spiral Tube and Autofeed Chamber (10 pack) | Hospital and long term care facilities |
| 900PT560 | Air Spiral Tube (10 pack) | Home and long term care facilities |
| 900PT560E | Air Spiral Tube (single pack) | Home and long term care facilities |
Indications For Use
The 900PT561 heated breathing tube is for delivery of humidified respiratory gases. For use with AIRVO™ and AIRVO™ 2 Series humidifiers in hospitals and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.
{4}------------------------------------------------
The 900PT560 and 900PT560E heated breathing tube is for delivery of humidified respiratory gases. For use with myAIRVO™ and myAIRVO™ 2 Series humidifiers in homes and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.
Compatible patient interfaces: nasal cannula, tracheostomy direct connection, mask adapter.
Technological Characteristics Comparison
The AirSpiral Heated Breathing Tube is a new accessory device designed with a new tube wall and heater wire construction and patient interface connector compared to the existing predicate corrugated heated breathing tube accessory.
The predicate corrugated breathing tube and proposed AirSpiral breathing tube are accessories for use with the AIRVO/AIRVO 2 and myAIRVO/myAIRVO 2 Series Humidifiers. The proposed breathing tube provides better thermal insulation from ambient cooling effects when compared to the predicate corrugated tubing due to the spiral wound construction of the tube wall, having trapped air and placement of the heater wire in the plastic tube wall. The predicate tube in contrast has an extruded plastic tube wall and heater wire within the gas path.
The intended use of the new device is identical to the intended use of the predicate Heated Breathing Tubes cleared by K131895 [AIRVO 2 Series Humidifier]. The following table summarizes the comparison between the new and predicate breathing tube accessories.
Substantial Equivalence Comparison Summary
Similarities
| Design/technologicalcharacteristic | New device(AirSpiral Breathing Tube) | Predicate device(Corrugated Breathing Tube) |
|---|---|---|
| Indications For Use | The 900PT561 heated breathing tube is for delivery of humidified respiratory gases. For use with AIRVOTM and AIRVOTM 2 Series humidifiers in hospitals and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.The 900PT560 and 900PT560E heated breathing tube is for delivery of humidified respiratory gases. For use with myAIRVOTM and myAIRVOTM 2 Series humidifiers in homes and long-term care facilities. For use at flows from 2 to 60 L/min depending on the patient interface.Compatible patient interfaces: nasal cannula, tracheostomy direct connection, mask adapter. | The AIRVO 2 and myAIRVO 2 humidifiers are for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases. This includes patients who have had upper airways bypassed. The flow may be from 2 - 60 L/min depending on the patient interface. The AIRVO 2 is for patients in hospitals and long-term care facilities. The myAIRVO 2 is for patients in homes and long-term care facilities. |
| Principle ofOperation | Connected to the AIRVO or AIRVO 2 Series humidifiers. Powered by the humidifier to maintain heat as a conduit for humidified heated respiratory gases. | Connected to the AIRVO or AIRVO 2 Series humidifiers. Powered by the humidifier to maintain heat as a conduit for humidified heated respiratory gases. |
{5}------------------------------------------------
| Design/technologicalcharacteristic | New device(AirSpiral Breathing Tube) | Predicate device(Corrugated Breathing Tube) |
|---|---|---|
| Connects the humidifier to the patientinterface. | Connects the humidifier to the patientinterface. | |
| Target population | As per AIRVO/AIRVO 2 Serieshumidifiers, patients requiring flowsbetween 2 – 60 L/min. | As per AIRVO/AIRVO 2 Serieshumidifiers, patients requiring flowsbetween 2 - 60 L/min. |
| Useful life | Single patient use. | Single patient use. |
| 14 days in Hospital / Long-term carefacilities environments. | 14 days in Hospital / Long-term carefacilities environments. | |
| 60 days in Home care environments. | 60 days in Home care environments. | |
| Temperature sensor | An integrated temperature sensor atthe patient end of the tube eliminatesthe need for external probes, cables oradaptors. | An integrated temperature sensor atthe patient end of the tube eliminatesthe need for external probes, cables oradaptors. |
| Flow range | (2 to 60) L/min delivered. | (2 to 60) L/min delivered. |
| Default mode: 10 to 60 L/min | Default mode: 10 to 60 L/min | |
| Junior mode: 2 to 25 L/min | Junior mode: 2 to 25 L/min | |
| Breathing tubeheater wireresistance | 20.5 $Ω$ to 23.5 $Ω$ | 20.5 $Ω$ to 23.5 $Ω$ |
| Chambers | HC360 manual fill chamber,single patient reuse | HC360 manual fill chamber,single patient reuse |
| 900PT290E auto fill chamber,single patient use only | 900PT290E auto fill chamber,single patient use only |
Differences
| Design/technologicalcharacteristic | New device(AirSpiral Breathing Tube) | Predicate device(Corrugated Breathing Tube) |
|---|---|---|
| Length and diameter | 1.8 m, 13 mm Ø | 1.8 m, 22 mm Ø |
| Tube wall | Air filled sealed plastic strip wound in aspiral to form lumen wall. | Solid corrugated extruded plastic toform lumen wall. |
| Heater wire | Consists of an insulated filamentconductor.Double helix wound moulded into beadof tube wall. Heater wire is not directlyin the gas path. | Consists of an insulated filamentconductor.Double helix wound sitting inside tubein the gas path. Heater wire is in thegas path. |
| Patient endconnector | Multi connector to connect to all OPTnasal cannula for Default mode andJunior mode.Also connects to OPT tracheostomyand face mask interface extensions. | Requires breathing tube with connectorfor Default mode nasal cannula, and abreathing tube with connector for Juniormode nasal cannula, to be able toconnect to all OPT nasal cannula.Also connects to OPT tracheostomyand face mask interface extensions. |
{6}------------------------------------------------
| Design/technological | New device | Predicate device |
|---|---|---|
| characteristic | (AirSpiral Breathing Tube) | (Corrugated Breathing Tube) |
| Model variants(single patient use) | 900PT561:AirSpiral tube and 900PT290Vchamber (10 pack) (Hospital) (Defaultand Junior mode) | 900PT501:Corrugated tube and 900PT290Vchamber (10 pack) (Hospital) (Defaultmode) |
| 900PT560:AirSpiral tube no chamber (10 pack)(Home) (Default and Junior mode) | 900PT500:Corrugated tube no chamber (10 pack)(Home) (Default mode) | |
| 900PT560E:AirSpiral tube no chamber (single)(Home) (Default and Junior mode) | 900PT500E:Corrugated tube no chamber (single)(Home) (Default mode) | |
| 900PT531:Corrugated tube and 900PT290Vchamber (10 pack) (Hospital) (Juniormode) | ||
| The 900PT56x tubes can be used withboth AIRVO 2 modes "Default" and"Junior", depending upon the patientinterface, due to the patient end multiconnector | The 900PT50x tubes are intended tobe used with AIRVO 2 "Default" mode,while 900PT531 is intended to be usedwith AIRVO 2 "Junior Mode". | |
| Patient Interfaces | OPT316, OPT318 Junior NasalCannula (AIRVO 2 Series only) | OPT316, OPT318 Junior NasalCannula (AIRVO 2 Series only) |
| OPT012 Wigglepads spare part | OPT012 Wigglepads spare part | |
| All are single patient use only | All are single patient use | |
| OPT942, OPT944, OPT946 NasalCannula (and "E' models) | OPT842, OPT844, OPT846 NasalCannula (and "E' models) | |
| OPT970 Tracheostomy DirectConnection (and "E' models) | OPT870 Tracheostomy DirectConnection (and "E' models) | |
| OPT980 Mask Interface Adapter (and"E' models) | RT013 Mask Interface Adapter (and "E'models) | |
| All are single patient use only | All are single patient use only |
Non-Clinical Performance Data
Assessment of non-clinical performance data is used in the determination of substantial equivalence. The AirSpiral Heated Breathing Tube has undergone non-clinical testing and risk management that covers pneumatic, electrical and thermal safety, environmental conditions, functional verification and performance testing.
The following were tested to support the substantial equivalence decision:
- . Condensation testing, to show an improvement in condensate accumulation over the predicate line of tubes.
- Pressure loss with bending
- . Leak testing with and without an interface
- . Connection forces for each connector
- . Tensile strength of the tube
{7}------------------------------------------------
- . Useful life, to show that tubes will last at least 2 weeks in the hospital or long term care facility environment and 60 days in the home and long term care environments and pass leak test, electrical test and pull test.
- Compatibility of tube parts and components with oxygen under normal conditions and single-fault conditions.
- . Device to function normally after storage, transportation and drop testing using ISTA 2A
Results showed that the proposed AirSpiral Heated Breathing Tubes passed the acceptance criteria for all tests.
The AirSpiral Heated Breathing Tubes were also assessed in conjunction with the AIRVO 2 Series Humidifiers to test system performance to ISO 8185: 2007.
Results showed that ISO 8185 limits were met for key attributes:
- Maximum accessible surface temperature of the delivery tube with 25 cm of patient ● connection port: Surface temperature < 44 °C.
- Maximum delivered gas temperature in normal use: Delivered temperature < 43 °C.
- Heating is interrupted to the heater-plate and breathing tube heater wire in single fault condition: Heating stopped when delivered gas temperature > 43 °C.
- . Maximum thermal overshoot enthalpy at patient connection port: Overshoot specific enthalpy < 194 kJ.kq-1.
- . Minimum humidity output for invasive and non-invasive patient interfaces: Humidity output > 33 mg.L-1 for invasive and > 10 mg.L-1 for non-invasive patient interfaces.
Biocompatibility
Biocompatibility evaluation of Cytotoxicity, Sensitization, Muscle Implantation, Genotoxicity and Extractables/Leachables for the 900PT561 AirSpiral Heated Breathing Tube and patient interfaces was conducted in accordance with FDA guidance document "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" (June 2016).
Extractables and leachables testing for chemical characterization was conducted on the AirSpiral Heated Breathing Tube and patient interfaces using worst-case volume of condensate measured. A toxicological risk assessment based on the chemical characterization testing was performed for each chemical observed following recommendations outlined in ISO 10993-17:2002: Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances, with margin of safety calculated for each chemical characterized.
Standards
The device complies with the following applicable product standards:
| ISO 8185: 2007 | Respiratory tract humidifiers for medical use - Particular requirementsfor respiratory humidification systems |
|---|---|
| IEC 60601-1:1988 | Medical Electrical Equipment, Part 1: General Requirements forSafety + A1:1991+A2:1995 |
| IEC 60601-1-2:2007 | General requirements for basic safety and essential performance -Collateral standard: Electromagnetic compatibility - Requirementsand tests |
{8}------------------------------------------------
| ISO 10993-1:2009 | Biological evaluation of medical devices -- Part 1: Evaluation andtesting within a risk management process |
|---|---|
| ISO 10993-3:2003 | Tests for genotoxicity, carcinogenicity, and reproductive toxicity |
| ISO 10993-5:2009 | Tests for in vitro cytotoxicity |
| ISO 10993-6:2007 | Tests for local effects after implantation |
| ISO 10993-10:2010 | Tests for irritation and skin sensitization |
Clinical Performance Data
No Clinical Performance Data was used to support substantial equivalence.
Conclusions
Testing carried out on the AirSpiral Heated Breathing Tubes indicates that they meet design, performance, and biocompatibility requirements. The AIRVO 2 Series Humidifier System, when used with the AirSpiral Heated Breathing Tubes, complies with the standards for medical electrical equipment and respiratory humidifiers for safety and performance.
The results obtained demonstrate that the AirSpiral Heated Breathing Tubes are substantially equivalent to the predicate.
§ 868.5450 Respiratory gas humidifier.
(a)
Identification. A respiratory gas humidifier is a device that is intended to add moisture to, and sometimes to warm, the breathing gases for administration to a patient. Cascade, gas, heated, and prefilled humidifiers are included in this generic type of device.(b)
Classification. Class II (performance standards).